The Revisited Role of Ultrasound Guided Core Needle Biopsy in the Breast Cancer Diagnosis

Mocian, Flavius; Georgescu, Rareş; Coroș, Marius Florin; Colcer, Ioana; Hanko, Bauer Orsolya; Oprea, Adela-Luciana; Stolnicu, Simona

doi:10.21614/chirurgia.113.2.244

Cited by 3 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ultrasound-guided core needle biopsy is an accurate method for evaluating breast masses [ 12 ], which has been widely used in clinics. However, due to its spring drive, its controllability in exciting moments remains poor.…”

Section: Discussionmentioning

confidence: 99%

A comparative study on ultrasound-guided elite, Mammotome, and core needle biopsy for diagnosing malignant breast masses

et al. 2019

View full text Add to dashboard Cite

Introduction: The present study aims to clarify the advantages and disadvantages of elite biopsy, to provide a reference for selecting the puncture method. Material and methods: A total of 802 patients with a BI-RADS grade ≥ 4, as evaluated by the molybdenum target, and measurable lesions revealed by colour Doppler ultrasound, who were admitted at our department from January 2017 to January 2018, were enrolled in the present study. These patients were randomly divided into three groups: elite, Mammotome and core needle biopsy groups. The pathological underestimation rate, diagnostic accordance rate, haematoma incidence rate, and costs of these three biopsy methods were compared. Results: The difference in diagnostic accordance rates between the elite biopsy group and core needle biopsy group was statistically significant (98.9% vs. 94.7%, p = 0.003), as well as between the Mammotome biopsy group and core needle biopsy group (99.6% vs. 94.7%, p < 0.001). The difference in pathological underestimation rates between the elite biopsy group and core needle biopsy group was statistically significant (7.2% vs. 37.3%, p < 0.001), as well as between the Mammotome biopsy group and core needle biopsy group (1.6% vs. 7.2%, p < 0.001). The difference between the Mammotome biopsy group and elite biopsy group was not statistically significant. The incidence of haematoma in the Mommotome, elite, and core needle groups was 15.9%, 13%, and 21.7%, respectively (13% vs. 21.7%, p = 0.021). Conclusions: Elite biopsy has a low rate of pathological underestimation and low incidence of haematoma, can improve the breast conserving rate, and has an affordable cost. As a biopsy method with high accuracy, safety, and economy, elite biopsy can be widely used in clinics.

show abstract

Section: Discussionmentioning

confidence: 99%

A comparative study on ultrasound-guided elite, Mammotome, and core needle biopsy for diagnosing malignant breast masses

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Imaging studies of the breast and preoperative core needle biopsy of suspicious nodules play a vital role in the diagnostic process, facilitate early diagnosis of cancer, and set the course for personalized treatment. 4,5 In breast-conserving removal of non-palpable lesions preoperative marking is used in order to ensure clean surgical margins. 6 The successful management of breast cancer requires senologist-coordinated interdisciplinary collaboration.…”

mentioning

confidence: 99%

Multidisciplinary Approach in the Management of a Small, Non-Palpable Breast Tumor

Lőrincz¹,

Baróti

2020

Journal of Interdisciplinary Medicine

View full text Add to dashboard Cite

Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass

Diab,

Zaidan,

Samir

et al. 2023

Journal of the Arab Society for Medical Research

View full text Add to dashboard Cite

Background/aim A crucial approach for finding breast cancer sooner is the triple examination of breast diseases. Our goal was to determine if ultrasound-guided core biopsies were required to investigate clinically ambiguous breast tumors that lacked imaging features suspicious for malignancy in Breast Imaging Reporting and Data System 3. Patients and methods A prospective study was performed on 50 patients fulfilling our eligibility criteria who presented with symptomatic indeterminate breast masses chosen according to our selection criteria and underwent an ultrasonography-guided core biopsy in the period from January 2021 to March 2022. Results A total of 50 clinically ambiguous breast masses were investigated, of which 47 (94%) were benign lesions, including 34 (68%) lesions were fibroadenomas, six (12%) lesions were fibrocystic disorder without ductal hyperplasia, one (2%) lesion was fibrocystic disease with ductal hyperplasia with no atypia, and six (12%) lesions showed periductal mastitis. Two (4%) lesions were proliferative breast lesions with focal atypia. One (2%) lesion was infiltrating duct carcinoma grade 2. Conclusion Ultrasound-guided core biopsy is necessary for investigating clinically indeterminate breast mass in symptomatic patients with Breast Imaging Reporting and Data System 3 finding on imaging, for early detection of malignancy and atypical hyperplastic changes.

show abstract

The Revisited Role of Ultrasound Guided Core Needle Biopsy in the Breast Cancer Diagnosis

Cited by 3 publications

References 18 publications

A comparative study on ultrasound-guided elite, Mammotome, and core needle biopsy for diagnosing malignant breast masses

A comparative study on ultrasound-guided elite, Mammotome, and core needle biopsy for diagnosing malignant breast masses

Multidisciplinary Approach in the Management of a Small, Non-Palpable Breast Tumor

Evaluation of core-needle biopsy in Breast Imaging Reporting and Data System 3 breast mass

Contact Info

Product

Resources

About